Literature DB >> 31742172

Comparison of central venous catheter in brachiocephalic vein and internal jugular vein for the incidence of complications in patients undergoing radiology.

Azim Motamedfar1, Mohammad M Gharibvand1, Asadollah Jalil1.   

Abstract

INTRODUCTION: Central venous catheter (CVC) is an essential part of modern medical care that delivers the drugs, intravenous fluids, and intravenous feeding to the vein. So far, limited studies have been carried out on the brachiocephalic vein (BCV) in adults. This study aimed to compare the CVC in the internal jugular vein (IJV) and BCV in order to ease of access and incidence of complication such as infectious and mechanical complications.
MATERIALS AND METHODS: This clinical trial was performed on 52 patients who underwent BCV and the IJV catheterization. The patients were compared in two groups of IJV and BCV in order to facilitate catheterization and measure the success rate and catheterization-induced complications. The difference between the two groups was analyzed by Independent t-test and Chi-square tests.
RESULTS: Overall, 52 patients underwent intravenous catheterization. The success rate of catheterization in the first attempt was 100%. The problems of catheterization procedure in the IJV group (11.5%) were greater than the BCV group (6.6%). There was no significant difference between the two groups regarding the duration of catheterization, pneumothorax, emphysema, hematoma, arterial puncture, infection, and complete thrombosis, whereas the partial thrombosis in the IJV group (30.76%) was significantly (P < 0.05) greater than the BCV group (23.07%).
CONCLUSION: Catheterization in both brachiocephalic and the IJV is an appropriate, highly efficient, stable, and safe procedure and ultrasound-guided catheterization is very reliable and safe method. Copyright:
© 2019 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Brachiocephalic vein; catheterization; central vein; internal jugular vein; ultrasound

Year:  2019        PMID: 31742172      PMCID: PMC6857370          DOI: 10.4103/jfmpc.jfmpc_205_19

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

In modern medical centers, about 80% of the patients receive medication, liquids, nutrients, and blood products through the central and peripheral veins during the admission.[12] The central venous access (especially interventional radiology) is of particular importance for managing the patients in the intensive care unit.[3] Central venous catheter (CVC) is a necessary part of modern medical care that allows the delivery of medications, intravenous fluids, intravenous feeding, and hemodialysis. CVC can be used to monitor the hemodynamic changes.[456] CVC is sometimes associated with adverse complications, including infectious, mechanical, and thrombotic complications.[67] The most common complication due to CVC over 72 h is an infectious disorder that occurs locally in the entrance of the catheter and blood, occurring in 5%–26% of cases.[8] Given their proper location, high blood flow, and easier access, jugular veins are widely used. In this method, the probability of developing pneumothorax and thrombosis is lower. However, it should be taken into account that these catheters cause discomfort in patients, especially when moving the neck. Catheters increase the probability of being infected, compared with the subclavian catheter. On the other hand, access to the subclavian vein is difficult and time-consuming and increases the likelihood of damage to the subclavian artery, pneumothorax, and hemothorax. It should be pointed out that it is less infectious, and it is easier for the patient to tolerate.[9] Given the possible infection and thrombosis following the use of internal jugular veins (IJVs) and subclavian, one has to consider alternatives to reduce these complications. Therefore, targeting the brachiocephalic vein (BCV) and using ultrasound for the administration of CVC may reduce the incidence of complications associated with catheterization and vascular access.[10] BCV cannulation, supraclavicular procedure, and ultrasound can contribute to this to a great extent, especially in children.[1112] Accordingly, this study aimed to compare the placement of central vein catheter in IJV and brachiocephalic in terms of ease of access and incidence of infectious and mechanical complications in the patients at the Radiology Departments of Imam Khomeini Hospital and Ahvaz Hospital in 2018.

Materials and Methods

This clinical trial was performed on 52 patients aged 18–80 years. Patients were randomly divided into two groups (IJV and brachiocephalic). Once the patients filled out the informed consent, demographic characteristics and BMI of each patient were recorded individually. All of the patients were provided with important information about the condition before the placement of catheter, such as trauma of head and neck edema, variations in anatomy, previous neck surgeries, burns, central venous thrombosis, coagulopathy, and tracheostomy. In this study, all of the patients who did not have a previous history of catheterization were selected. In addition, all catheterization procedures were performed under local anesthesia, and none of the patients needed sedation. Jugular vein and right BCVs were selected for convenient access. Then, the standard process of placing CVC was performed as follows: The patient was placed in the supine position, and the patient's neck was bended to the left. The site of the catheter was sterilized using a chlorhexidine or betadine solution, and a special perforated fabric was placed on the site. Then, the guidewire was introduced. After the dilatation, a catheter was inserted using the dilator. Finally, the catheter was fixed using nylon or silk thread. The patient was examined in terms of acute complications.

Analysis

Data were analyzed using SPSS v20 (SPSS Inc., Chicago, IL, USA). Moreover, P < 0.05 was considered as the level of significance.

Results

This clinical trial was performed on 52 patients in Imam Khomeini Hospital and Golestan Ahvaz Hospital in 2018. Patients were selected from people who did not have a history of catheterization. All procedures were performed in an outpatient operating room at the Interventional Radiology Department under local anesthesia. Patients who had expired due to underlying causes were excluded. The patients were divided into two groups of IJV catheter and BCV. Accordingly, catheterization was performed well in all patients. The general characteristics and demographics of patients are shown in Table 1. The duration of the procedure in both groups was examined [Tables 2 and 3]. The duration of cannulation was calculated, considering all factors. The entire duration of the procedure is from local anesthetic to catheter fixation. Patients catheterized via the BCV approach were then compared with those catheterized via the IJV in terms of ease of catheterization, success rate, and complications. Differences between approaches were assessed by univariate analyses and multivariable analysis.
Table 1

Baseline characteristics of the patient population (n=52)

DemographicsBrachiocephalic vein (n=26)Internal jugular vein (n=26)
Age (18-80) year4036
Weight (kg)8078
Body mass index (kg/m2)26.225.5
Gender
 Male14 (53.84)17 (65.38)
 Female12 (46.15)9 (34.61)
Table 2

Complication and success rates, by insertion site

ParameterBrachiocephalic vein (n=26)Internal jugular vein (n=26)P
Time
 Total4-5.3 min3.8-6 minP>0.05
 Cannulation2.2 min±10 s2 min±7 sP>0.05
Success at first puncture26 (100)26 (100)
Any procedural difficulty2 (7.69)3 (11.53)P>0.05
Insertion failure00
Previous history of catheterization00
Table 3

Complication after brachiocephalic and internal jugular central venous catheter

ComplicationsBrachiocephalicInternal jugularP
PneumothoraxNo complicationsNo complications
HematomaNo complications1 (3.84) HematomaP>0.05
EmphysemaNo complicationsNo complications
Arterial punctureNo complicationsNo complications
Infection2 (7.69)No complicationsP>0.05
Need remove the catheter due to complicationsNo needNo need
Partial thrombosis6 (23.07)8 (30.76)P<0.05
Complete thrombosisNo complicationsNo complications
Baseline characteristics of the patient population (n=52) Complication and success rates, by insertion site Complication after brachiocephalic and internal jugular central venous catheter The complications of placing CVC and internal jugular were compared, and a variety of complications were shown for the patients [Table 2]. These complications were divided into three classes: acute (>24 h), subacute (24 h to 3 weeks), and chronic (3 weeks to 3 months). The complications included arterial pancture, pneumothorax, emphysema, hematoma, infections, and chronic complications. Accordingly, partial thrombosis and complete venous thrombosis were examined. The average days of using CV-line catheter in the BCV and the IJV were 13 and 18 days, respectively. The catheter was then removed in all cases because the treatment was over and there was no need for a catheter.

Discussion

In previous studies, IJV and subclavian vein have been used for catheterization in infants and adults. It should be kept in mind that patients do not feel comfortable to use these catheters, especially when moving the neck. On the other hand, access to the subclavian vein is difficult and time-consuming. It may also increase the likelihood of damage to the subclavian artery, pneumothorax, and hemothorax, although it is less infectious and it is easier for the patient to tolerate.[1314] In many cases, the use of BCVs is essential as a substitute for other central venous organs in many emergency patients, especially infants. So far, limited studies have been carried out on catheterization in BCVs in adults.[15] Given the acute and chronic complications of catheterization in central veins, such as IJV, femoral vein, and subclavian vein, this study aimed to evaluate the use of CVC in brachiocephalic in terms of ease of catheterization, success rate, and complications. The results showed that the use of CVC in BCV is an appropriate strategy since it is capable of reducing chronic and acute complications of catheterization. Approximately 6 million CVCs are placed annually in European countries and the United States. Accordingly, IJVs, subclavian veins, and femoral veins are prioritized as the main targets.[16] The catheterization process showed that BCV has several advantages over the IJV in terms of anatomy. The BCV tissue is thinner and has a greater lumen. More importantly, it is easily detected by ultrasound. On the other hand, it does not overlap with carotid arteries and brachiocephalic arteries. In addition, the catheter entrance is distant from the naso-buccal area and the probability of being infected with oropharyngeal floor is reduced. Accordingly, the patient is unlikely to feel pain in the neck.[171819] In this study, in both branchiocephalic and internal jugular vein catheterization, acute complications, (<24 h) including arterial pancture, pneumothorax, and emphysema were not observed in any of the patients. Subacute complications (from 24 h to 3 weeks) included hematoma and infections; however, hematoma was observed in the IJV group. There was no need to remove the catheter in any cases. Chronic complications (from 3 weeks to 3 months) included partial thrombosis and complete venous thrombosis. Partial thrombosis was observed in both BCV and IJV. Similarly, Habas et al. examined the complications of CVC administration in BCVs compared with other veins. They showed that the level of infection and thrombosis in the BCV was less than the jugular and subclavian vein catheters.[11] Moreover, Oulego-Erroz et al. investigated the use of CVC in BCV. They did not find any complications due to catheter administration in the BCV during and after the cannulation. Researchers argued that this method was efficient, accessible, and safe.[20] Similarly, Di Nardo et al. introduced left BCV cannulation as a safe and low-risky method.[21] Beccaria et al. suggested that BCV can be an appropriate alternative to cannulation in other central veins.[15] Thompson et al. suggested the use of BCV for central venous access in short-term admissions.[22] Jordan et al. compared the use of central vein catheter in BCVs with IJV and subclavian vein. They showed that the complications of CVC administration, including infections (<5%) and thrombosis, were reduced in BCV compared with two other groups.[12] In this study, infection was observed in two patients. However, there was no significant difference between the IJV and BCV in terms of the level of infection. Other parameters such as the duration of cannulation and the acute and subacute complications were similar in both groups.

Conclusion

The results showed that the ease of catheter placement in the BCV and the incidence of acute and chronic complications in this vein were similar to that of the IJV. On the other hand, given the fact that ultrasound is a very reliable and safe method, the ultrasound-guided catheterization in BCV can be regarded as an alternative method.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  21 in total

1.  Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.

Authors:  H Lorch; M Zwaan; C Kagel; H D Weiss
Journal:  Cardiovasc Intervent Radiol       Date:  2001 May-Jun       Impact factor: 2.740

2.  Intravascular Complications of Central Venous Catheterization by Insertion Site.

Authors:  Jean-Jacques Parienti; Nicolas Mongardon; Bruno Mégarbane; Jean-Paul Mira; Pierre Kalfon; Antoine Gros; Sophie Marqué; Marie Thuong; Véronique Pottier; Michel Ramakers; Benoît Savary; Amélie Seguin; Xavier Valette; Nicolas Terzi; Bertrand Sauneuf; Vincent Cattoir; Leonard A Mermel; Damien du Cheyron
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

3.  Does ultrasound imaging before puncture facilitate internal jugular vein cannulation? Prospective randomized comparison with landmark-guided puncture in ventilated patients.

Authors:  Hideaki Hayashi; Masaru Amano
Journal:  J Cardiothorac Vasc Anesth       Date:  2002-10       Impact factor: 2.628

4.  Ultrasound-guided supraclavicular access to the innominate vein for central venous cannulation.

Authors:  Janeen R Jordan; Ernest E Moore; James Haenel; Clay Cothren Burlew
Journal:  J Trauma Acute Care Surg       Date:  2014-05       Impact factor: 3.313

5.  Supraclavicular catheterization of the brachiocephalic vein: a way to prevent or reduce catheter maintenance-related complications in children.

Authors:  Flora Habas; Julien Baleine; Christophe Milési; Clémentine Combes; Marie-Noëlle Didelot; Sara Romano-Bertrand; Delphine Grau; Sylvie Parer; Catherine Baud; Gilles Cambonie
Journal:  Eur J Pediatr       Date:  2018-01-10       Impact factor: 3.183

6.  The Brachiocephalic Vein as a Safe and Viable Alternative to Internal Jugular Vein for Central Venous Cannulation.

Authors:  Paolo Federico Beccaria; Simona Silvetti; Rosalba Lembo; Giovanni Landoni; Giacomo Monti; Massimo Zambon; Daniela Mamo; Alberto Zangrillo
Journal:  Anesth Analg       Date:  2018-07       Impact factor: 5.108

7.  Ultrasound-guided subclavian vein cannulation in infants: supraclavicular approach.

Authors:  Ossam Rhondali; Rachid Attof; Sylvie Combet; Dominique Chassard; Mathilde de Queiroz Siqueira
Journal:  Paediatr Anaesth       Date:  2011-06-01       Impact factor: 2.556

8.  Is routine replacement of peripheral intravenous catheters necessary?

Authors:  T Bregenzer; D Conen; P Sakmann; A F Widmer
Journal:  Arch Intern Med       Date:  1998-01-26

9.  An epidemiologic study of the risks associated with peripheral intravenous catheters.

Authors:  I B Tager; M B Ginsberg; S E Ellis; N E Walsh; I Dupont; E Simchen; G A Faich
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

Review 10.  Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization.

Authors:  Patrick Brass; Martin Hellmich; Laurentius Kolodziej; Guido Schick; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.